Post

Personalized cancer vaccine from Moderna, Merck shows promise in first late-stage melanoma trial

cnb.cxPersonalized cancer vaccine from Moderna, Merck shows promise in first late-stage melanoma trialThe combination regimen significantly extended the time patients lived without their melanoma returning, compared with Keytruda alone.

19/8/26, 10:49 am3 reposts12 likes

juanrive 🇺🇦

@juanrive.bsky.social

If it’s late stage, is it really a vaccine or a treatment?